Clinical trial

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

NCT06193486

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-26

PhasePHASE1

Study timeline

Study start (actual)2024-10-26Date precision: day

Registry last updated2026-03-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancerunresolved

Interventions

MSGV1-PSCA-8T28ZBIOLOGICAL

FludarabineDRUG · verified · RxNorm: fludarabine

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

Sponsors & collaborators

H. Lee Moffitt Cancer Center and Research Institutelead sponsor

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06193486 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.